Order Article Reprints

Spirin P, Vedernikova V, Volkava T, Morozov A, Kleymenova A, Zemskaya A, Shyrokova L, Porozov Y, Glumakova K, Lebedev T, et al. New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis. Pharmaceutics. 2025; 17(4):416. https://doi.org/10.3390/pharmaceutics17040416

Spirin, Pavel, Valeria Vedernikova, Tatsiana Volkava, Alexey Morozov, Alla Kleymenova, Anastasia Zemskaya, Lena Shyrokova, Yuri Porozov, Ksenia Glumakova, Timofey Lebedev, and et al. 2025. "New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis" Pharmaceutics 17, no. 4: 416. https://doi.org/10.3390/pharmaceutics17040416

Spirin, P., Vedernikova, V., Volkava, T., Morozov, A., Kleymenova, A., Zemskaya, A., Shyrokova, L., Porozov, Y., Glumakova, K., Lebedev, T., Kozlov, M., & Prassolov, V. (2025). New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis. Pharmaceutics, 17(4), 416. https://doi.org/10.3390/pharmaceutics17040416